Imagine you are the chief financial officer (CFO) of a corporation with plans to complete the acquisition of a critical subsidiary during the current year. Your chief executive officer (CEO) has requested a presentation to the Board of Directors describing the methods available to account for the acquisition internally and the best method for the company during the acquisition year. Please describe the value of each method identified in your presentation to the Board and support your recommendation with examples in a memo style to the Board of Directors. Compare the key differences between the U.S. GAAP and IFRS positions on both intangible research and development costs and tangible depreciable assets. Indicate the key benefits and drawbacks to financial statement users of each method (U.S. GAAP and IFRS). Next, determine the method that provides the most relevant information to financial statement users. Provide support for your rationale.